Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Molecular Testing of Serial Blood Specimens from Patients with Early Lyme Disease during Treatment Reveals Changing Coinfection with Mixtures of Borrelia burgdorferi Genotypes.

Mosel MR, Carolan HE, Rebman AW, Castro S, Massire C, Ecker DJ, Soloski MJ, Aucott JN, Eshoo MW.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00237-19. doi: 10.1128/AAC.00237-19. Print 2019 Jul.

PMID:
31036693
2.

Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET.

Coughlin JM, Yang T, Rebman AW, Bechtold KT, Du Y, Mathews WB, Lesniak WG, Mihm EA, Frey SM, Marshall ES, Rosenthal HB, Reekie TA, Kassiou M, Dannals RF, Soloski MJ, Aucott JN, Pomper MG.

J Neuroinflammation. 2018 Dec 19;15(1):346. doi: 10.1186/s12974-018-1381-4.

3.

Robust B Cell Responses Predict Rapid Resolution of Lyme Disease.

Blum LK, Adamska JZ, Martin DS, Rebman AW, Elliott SE, Cao RRL, Embers ME, Aucott JN, Soloski MJ, Robinson WH.

Front Immunol. 2018 Jul 18;9:1634. doi: 10.3389/fimmu.2018.01634. eCollection 2018.

4.

Induction and Measurement of Cytotoxic T Lymphocyte Activity.

Wonderlich J, Shearer G, Livingstone A, Brooks A, Soloski MJ, Presby MM.

Curr Protoc Immunol. 2018 Feb 21;120:3.11.1-3.11.29. doi: 10.1002/cpim.38.

PMID:
29512145
5.

The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome.

Rebman AW, Bechtold KT, Yang T, Mihm EA, Soloski MJ, Novak CB, Aucott JN.

Front Med (Lausanne). 2017 Dec 14;4:224. doi: 10.3389/fmed.2017.00224. eCollection 2017.

6.

Flow cytometric discrimination of seven lineage markers by using two fluorochromes.

Boin F, Giardino Torchia ML, Borrello I, Noonan KA, Neil M, Soloski MJ, Cimbro R.

PLoS One. 2017 Nov 30;12(11):e0188916. doi: 10.1371/journal.pone.0188916. eCollection 2017.

7.

CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.

Aucott JN, Soloski MJ, Rebman AW, Crowder LA, Lahey LJ, Wagner CA, Robinson WH, Bechtold KT.

Clin Vaccine Immunol. 2016 Sep 6;23(9):757-66. doi: 10.1128/CVI.00071-16. Print 2016 Sep.

8.

Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease.

Bouquet J, Soloski MJ, Swei A, Cheadle C, Federman S, Billaud JN, Rebman AW, Kabre B, Halpert R, Boorgula M, Aucott JN, Chiu CY.

MBio. 2016 Feb 12;7(1):e00100-16. doi: 10.1128/mBio.00100-16.

9.

Quantification of Borrelia burgdorferi Membrane Proteins in Human Serum: A New Concept for Detection of Bacterial Infection.

Cheung CS, Anderson KW, Benitez KY, Soloski MJ, Aucott JN, Phinney KW, Turko IV.

Anal Chem. 2015 Nov 17;87(22):11383-8. doi: 10.1021/acs.analchem.5b02803. Epub 2015 Nov 4.

10.

Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.

Lahey LJ, Panas MW, Mao R, Delanoy M, Flanagan JJ, Binder SR, Rebman AW, Montoya JG, Soloski MJ, Steere AC, Dattwyler RJ, Arnaboldi PM, Aucott JN, Robinson WH.

J Clin Microbiol. 2015 Dec;53(12):3834-41. doi: 10.1128/JCM.02111-15. Epub 2015 Oct 7.

11.

Immune response to intrapharyngeal LPS in neonatal and juvenile mice.

McGrath-Morrow SA, Lee S, Gibbs K, Lopez A, Collaco JM, Neptune E, Soloski MJ, Scott A, D'Alessio F.

Am J Respir Cell Mol Biol. 2015 Mar;52(3):323-31. doi: 10.1165/rcmb.2014-0100OC.

12.

Serum inflammatory mediators as markers of human Lyme disease activity.

Soloski MJ, Crowder LA, Lahey LJ, Wagner CA, Robinson WH, Aucott JN.

PLoS One. 2014 Apr 16;9(4):e93243. doi: 10.1371/journal.pone.0093243. eCollection 2014.

13.

Multiparameter flow cytometry for discovery of disease mechanisms in rheumatic diseases.

Soloski MJ, Chrest FJ.

Arthritis Rheum. 2013 May;65(5):1148-56. doi: 10.1002/art.37847. No abstract available. Erratum in: Arthritis Rheum. 2014 Feb;66(2):427.

14.

Direct molecular detection and genotyping of Borrelia burgdorferi from whole blood of patients with early Lyme disease.

Eshoo MW, Crowder CC, Rebman AW, Rounds MA, Matthews HE, Picuri JM, Soloski MJ, Ecker DJ, Schutzer SE, Aucott JN.

PLoS One. 2012;7(5):e36825. doi: 10.1371/journal.pone.0036825. Epub 2012 May 8.

15.

Enterobacterial common antigen mutants of Salmonella enterica serovar Typhimurium establish a persistent infection and provide protection against subsequent lethal challenge.

Gilbreath JJ, Colvocoresses Dodds J, Rick PD, Soloski MJ, Merrell DS, Metcalf ES.

Infect Immun. 2012 Jan;80(1):441-50. doi: 10.1128/IAI.05559-11. Epub 2011 Oct 24.

16.

Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion.

Gandolfo MT, Jang HR, Bagnasco SM, Ko GJ, Agreda P, Soloski MJ, Crow MT, Rabb H.

Transpl Immunol. 2010 May;23(1-2):45-52. doi: 10.1016/j.trim.2010.04.002. Epub 2010 Apr 20.

17.

TRPV2 has a pivotal role in macrophage particle binding and phagocytosis.

Link TM, Park U, Vonakis BM, Raben DM, Soloski MJ, Caterina MJ.

Nat Immunol. 2010 Mar;11(3):232-9. doi: 10.1038/ni.1842. Epub 2010 Jan 31.

18.

MMP-12, a novel matrix metalloproteinase associated with giant cell arteritis.

Rodríguez-Pla A, Martínez-Murillo F, Savino PJ, Eagle RC Jr, Seo P, Soloski MJ.

Rheumatology (Oxford). 2009 Nov;48(11):1460-1. doi: 10.1093/rheumatology/kep271. Epub 2009 Sep 6. No abstract available.

19.

Normal mouse kidneys contain activated and CD3+CD4- CD8- double-negative T lymphocytes with a distinct TCR repertoire.

Ascon DB, Ascon M, Satpute S, Lopez-Briones S, Racusen L, Colvin RB, Soloski MJ, Rabb H.

J Leukoc Biol. 2008 Dec;84(6):1400-9. doi: 10.1189/jlb.0907651. Epub 2008 Sep 2.

20.

Association of a nonsynonymous single-nucleotide polymorphism of matrix metalloproteinase 9 with giant cell arteritis.

Rodríguez-Pla A, Beaty TH, Savino PJ, Eagle RC Jr, Seo P, Soloski MJ.

Arthritis Rheum. 2008 Jun;58(6):1849-53. doi: 10.1002/art.23457.

21.

High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis.

Ma X, Torbenson M, Hamad AR, Soloski MJ, Li Z.

Clin Exp Immunol. 2008 Jan;151(1):130-8. Epub 2007 Nov 7.

22.

Salmonella as an Inducer of Autoimmunity.

Soloski MJ, Metcalf ES.

EcoSal Plus. 2007 Apr;2(2). doi: 10.1128/ecosalplus.8.8.13.

PMID:
26443586
23.

Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury.

Ascon DB, Lopez-Briones S, Liu M, Ascon M, Savransky V, Colvin RB, Soloski MJ, Rabb H.

J Immunol. 2006 Sep 1;177(5):3380-7.

24.

Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.

Li Z, Soloski MJ, Diehl AM.

Hepatology. 2005 Oct;42(4):880-5.

PMID:
16175608
26.

Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis.

Li Z, Oben JA, Yang S, Lin H, Stafford EA, Soloski MJ, Thomas SA, Diehl AM.

Hepatology. 2004 Aug;40(2):434-41.

PMID:
15368448
27.

Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs.

Li L, Sullivan BA, Aldrich CJ, Soloski MJ, Forman J, Grandea AG 3rd, Jensen PE, Van Kaer L.

J Immunol. 2004 Sep 15;173(6):3707-15.

28.

Infection-induced expansion of a MHC Class Ib-dependent intestinal intraepithelial gammadelta T cell subset.

Davies A, Lopez-Briones S, Ong H, O'Neil-Marshall C, Lemonnier FA, Nagaraju K, Metcalf ES, Soloski MJ.

J Immunol. 2004 Jun 1;172(11):6828-37.

29.
30.

Taenia crassiceps cysticercosis: immune response in susceptible and resistant BALB/c mouse substrains.

López-Briones S, Lamoyi E, Fragoso G, Soloski MJ, Sciutto E.

Parasitol Res. 2003 Jun;90(3):236-42. Epub 2003 Mar 12.

PMID:
12783314
31.

A peptide from heat shock protein 60 is the dominant peptide bound to Qa-1 in the absence of the MHC class Ia leader sequence peptide Qdm.

Davies A, Kalb S, Liang B, Aldrich CJ, Lemonnier FA, Jiang H, Cotter R, Soloski MJ.

J Immunol. 2003 May 15;170(10):5027-33.

32.

The involvement of class Ib molecules in the host response to infection with Salmonella and its relevance to autoimmunity.

Soloski MJ, Metcalf ES.

Microbes Infect. 2001 Nov-Dec;3(14-15):1249-59. Review.

PMID:
11755413
33.

CD4+ TCRalphabeta T cells are critically involved in the control of experimental murine cysticercosis in C57BL/6J mice.

López-Briones S, Soloski MJ, Bojalil R, Fragoso G, Sciutto E.

Parasitol Res. 2001 Oct;87(10):826-32.

PMID:
11688888
34.

Physiological regulation of the immunological synapse by agrin.

Khan AA, Bose C, Yam LS, Soloski MJ, Rupp F.

Science. 2001 Jun 1;292(5522):1681-6. Epub 2001 May 10.

35.

Recognition of tumor cells by the innate immune system.

Soloski MJ.

Curr Opin Immunol. 2001 Apr;13(2):154-62. Review.

PMID:
11228407
36.

Gram-negative pathogens and molecular mimicry: is there a case for mistaken identity? Response.

Soloski MJ, Lo WF, Metcalf ES.

Trends Microbiol. 2000 Oct;8(10):446-7. No abstract available.

PMID:
11203234
37.

Host immune response to intracellular bacteria: A role for MHC-linked class-Ib antigen-presenting molecules.

Soloski MJ, Szperka ME, Davies A, Wooden SL.

Proc Soc Exp Biol Med. 2000 Sep;224(4):231-9. Review.

PMID:
10964257
38.

Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens.

Lo WF, Woods AS, DeCloux A, Cotter RJ, Metcalf ES, Soloski MJ.

Nat Med. 2000 Feb;6(2):215-8.

PMID:
10655113
39.

Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses.

Pérarnau B, Saron MF, Reina San Martin B, Bervas N, Ong H, Soloski MJ, Smith AG, Ure JM, Gairin JE, Lemonnier FA.

Eur J Immunol. 1999 Apr;29(4):1243-52.

41.

Tumor defense by murine cytotoxic T cells specific for peptide bound to nonclassical MHC class I.

Griffiths E, Ong H, Soloski MJ, Bachmann MF, Ohashi PS, Speiser DE.

Cancer Res. 1998 Oct 15;58(20):4682-7.

42.

Alloreactive cytotoxic T cells recognize minor transplantation antigens presented by major histocompatibility complex class Ib molecules.

Speiser DE, Bachmann MF, Soloski MJ, Forman J, Ohashi PS.

Transplantation. 1998 Sep 15;66(5):646-50.

PMID:
9753347
44.

Constitutive and regulated expression of the class IB molecule Qa-1 in pancreatic beta cells.

Chun T, Aldrich CJ, Baldeón ME, Kawczynski LV, Soloski MJ, Gaskins HR.

Immunology. 1998 May;94(1):64-71.

46.

Dominance of a single peptide bound to the class I(B) molecule, Qa-1b.

DeCloux A, Woods AS, Cotter RJ, Soloski MJ, Forman J.

J Immunol. 1997 Mar 1;158(5):2183-91.

PMID:
9036964
47.

Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor.

Khan AA, Soloski MJ, Sharp AH, Schilling G, Sabatini DM, Li SH, Ross CA, Snyder SH.

Science. 1996 Jul 26;273(5274):503-7.

PMID:
8662540
48.

Structural and functional characteristics of the class IB molecule, Qa-1.

Soloski MJ, DeCloux A, Aldrich CJ, Forman J.

Immunol Rev. 1995 Oct;147:67-89. Review. No abstract available.

PMID:
8847081
49.

MHC class I-restricted processing of transmembrane proteins. Mechanism and biologic significance.

Siliciano RF, Soloski MJ.

J Immunol. 1995 Jul 1;155(1):2-5. Review. No abstract available.

PMID:
7602096
50.

Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen.

Aldrich CJ, DeCloux A, Woods AS, Cotter RJ, Soloski MJ, Forman J.

Cell. 1994 Nov 18;79(4):649-58.

PMID:
7525079

Supplemental Content

Loading ...
Support Center